ClinicalTrials HQ

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Recruiting · NCT07570862 · Registry updated 2026-09-14
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorderRecruitingPhase 22026-09-14NCT07570862

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Fate Therapeutics7

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cross Creek Medical ClinicFayettevilleUnited States4
GNP ResearchCooper CityUnited States10
Kaiser Permanente FontanaFontanaUnited States2
Miami Dermatology and Laser ResearchMiamiUnited States3
Nicklaus Children's HospitalMiamiUnited States112
Providence Medical FoundationFullertonUnited States46
The University of Texas Southwestern Medical CenterDallasUnited States37
University of California IrvineIrvineUnited States7
University of California San FranciscoSan FranciscoUnited States1
University of Florida Clinical Research CenterGainesvilleUnited States6
University of Nebraska Medical CenterOmahaUnited States12
Wallace Rheumatic Studies CenterBeverly HillsUnited States2